Health impact of chemicals in plastics is handed down two generations
UC Riverside mouse study finds paternal exposure to phthalates increases risk of metabolic diseases in progeny
Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus
Study provides insights into fighting broad range of pathogen’s viral strains
Monkeypox explained
UC Riverside experts discuss disease symptoms, vaccines, and anxiety management
COVID-19 vaccines for very young children
UC Riverside vaccine expert David Lo shares his thoughts in a Q&A
UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
Should you get a second booster shot for COVID-19?
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
A potential antiviral for SARS and SARS-like coronaviruses
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Researchers develop molecular traps to target SARS-CoV-2
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
Scientists discover new avian immunological pathway
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines
Building robust collaborations to ‘ATTACK’ future pandemics
As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...
A more targeted therapy to treat inflammatory bowel disease
UC Riverside mouse study focuses on the receptor TNFR1
New hope for people living with a genetic cause of autism
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome
Study links high cholesterol, cardiovascular disease to plastics
UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals
How sepsis need not be fatal
UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency
Public lecture to focus on synthetic genome engineering
Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
Novel mechanism links genetic defect in IBD patients to gut leakiness
UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut
How concerned should we be about the Delta variant?
UC Riverside experts share their thoughts
Salton Sea aerosol exposure triggers unique and mysterious pulmonary response
UC Riverside mouse study suggests inflammation could play key role in progression to asthma
New method expands the world of small RNAs
PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs